close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar132Point67
Implied share price

Buy Undervalued by 12.5%

5% margin of safety What's this?

EV / EBITDA
Use Average
JNJ
Johnson & Johnson
NVS
Novartis AG (ADR)
Change
PFE
Pfizer Inc.
Change
MRK
Merck & Co., Inc.
Change
SGP
Schering-Plough Corporation
Change
13.82 12.21 13.2 11.9 9.04 25.26
All amounts in millions
from last financial year
         
Implied Share Price $132.67 $85.22 $40.24 $97.18 $14.22
Market Cap 322,696 212,603 207,930 171,277 118,198
Net Debt -18,515 16,599 15,609 12,985 4,798
Enterprise Value (EV) 304,181 209,620 223,539 184,261 51,349
Revenue 70,074 50,359 48,851 39,498 18,502
EBITDA 24,918 15,880 18,788 20,379 2,033
Percent 35.6 % 31.5 % 38.5 % 51.6 % 11.0 %
EBIT 21,172 10,655 13,631 14,004 860
Percent 30.2 % 21.2 % 27.9 % 35.5 % 4.6 %
Balance Sheet          
Total Assets 133,411 131,556 167,381 101,677 28,117
Total Liabilities 62,261 54,510 102,661 57,001 17,588
Shareholders Equity 71,150 77,046 64,720 44,676 10,529.0

Price history

Comments

No comments yet. Login to comment.